(Q28141612)

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Minimal requirements for peptide mediated activation of CD8+ CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Stabilization of beta-catenin by genetic defects in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

1 reference

7 January 2021

A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Genes coding for tumor antigens recognized by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Expression of mage genes by non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980028-X

7 January 2021